Nuwellis, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Nuwellis, Inc. files its 10-K, highlighting its focus on the Aquadex System for treating fluid overload and its commercial activities in heart failure, critical care, and pediatrics.
NASDAQ
Nuwellis, Inc.'s 10-K filing outlines the terms of its common and preferred stock, including voting rights, dividend entitlements, and anti-takeover provisions.